• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aurobindo Pharma Limited — Board Meeting, 05-11-2025: Outcome of Board Meeting

    05-11-2025 | 07:55 pm

    Aurobindo Pharma's board approved the financial results for the quarter and half-year. Consolidated Q2 revenue stood at ₹8,237 Cr, with PAT at ₹848 Cr. For the half-year, revenue reached ₹16,029 Cr, delivering ₹1,672 Cr in PAT. Q2 Basic EPS was ₹14.61.

    No comments yet. Be the first to comment!

    All announcements from Aurobindo Pharma Limited